Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Brain Drain And Recruitment Risks for EMA post UK Brexit Vote

Executive Summary

Retaining existing and recruiting new staff could be a challenge for the London-based European Medicines Agency as a result of the uncertainty over the future location of the agency following the decision by the UK to leave the EU.


Related Content

Brexit: EMA Could Lose Up To Half Its Staff If It Has To Move
Brexit: EMA To Bolster Regulatory Reserves Ahead Of Relocation
Japan Wants EMA To Stay In UK Post-Brexit
UK Pharma's 'Brexit Playbook' Might Envision New Regulator Roles
Settle Terms Before Brexit Divorce Is Final, Former EMA Chief Says
Brexit Talks Must Prioritize Patient Access, Avoid Regulatory Divergence – EFPIA





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts